⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
AGARWALEYE - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 2.9
| Stock Code | AGARWALEYE | Market Cap | 14,455 Cr. | Current Price | 457 ₹ | High / Low | 568 ₹ |
| Stock P/E | 245 | Book Value | 61.8 ₹ | Dividend Yield | 0.00 % | ROCE | 5.94 % |
| ROE | 1.31 % | Face Value | 1.00 ₹ | DMA 50 | 445 ₹ | DMA 200 | 454 ₹ |
| Chg in FII Hold | -0.12 % | Chg in DII Hold | 0.05 % | PAT Qtr | 14.6 Cr. | PAT Prev Qtr | 4.95 Cr. |
| RSI | 59.8 | MACD | 4.17 | Volume | 64,113 | Avg Vol 1Wk | 85,061 |
| Low price | 327 ₹ | High price | 568 ₹ | PEG Ratio | 1.61 | Debt to equity | 0.30 |
| 52w Index | 53.8 % | Qtr Profit Var | 80.3 % | EPS | 1.75 ₹ | Industry PE | 48.0 |
📊 AGARWALEYE shows limited potential for intraday trading. While quarterly profits have improved significantly, the stock is trading at extremely high valuations (P/E 245 vs industry 48) with weak efficiency metrics (ROCE 5.94%, ROE 1.31%). Momentum indicators are neutral (RSI 59.8, MACD positive), but volume is below average, reducing conviction for intraday moves.
- 💰 Optimal Buy Price: Around 450 ₹ (near DMA 50 support)
- 📈 Profit-Taking Exit Levels: 465 ₹ – 472 ₹ (short-term resistance)
- 📉 Stop-Loss / Loss Protection: 445 ₹ (below DMA 50)
- ⏱️ If Already Holding: Exit if price fails to sustain above 460 ₹ or if volume continues to decline below average while RSI trends downward.
Positive
- Quarterly PAT growth from 4.95 Cr. to 14.6 Cr. (80.3% increase)
- EPS improved to 1.75 ₹
- Stock trading above DMA 50 and DMA 200, showing near-term support
- PEG ratio at 1.61, relatively reasonable compared to P/E
Limitation
- Extremely high P/E (245), far above industry average
- Low ROCE (5.94%) and ROE (1.31%) indicate weak efficiency
- No dividend yield (0%), limiting shareholder return
- Volume below 1-week average, showing weak participation
Company Negative News
- FII holdings decreased (-0.12%)
- Valuation concerns with high P/E and low returns
Company Positive News
- Quarterly profit growth of 80.3% shows operational improvement
- DII holdings slightly increased (+0.05%)
- Stock trading near 52-week high (53.8% gain from low)
Industry
- Healthcare/eye care industry P/E at 48, showing sector growth
- Steady demand for healthcare services supports long-term outlook
Conclusion
⚖️ AGARWALEYE is not an ideal candidate for intraday trading due to stretched valuations and weak fundamentals. Momentum indicators show neutral bias, but low volume participation limits upside potential. Traders may consider cautious entries near 450 ₹ with tight stop-losses and exit around 465–472 ₹. If already holding, monitor closely and exit if price weakens below 445 ₹.